Sight Sciences, Inc. (SGHT)
8.34
-0.08
(-0.95%)
USD |
NASDAQ |
Sep 03, 16:00
8.34
0.00 (0.00%)
After-Hours: 19:09
Sight Sciences Shareholders Equity (Quarterly) : 52.89M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.89M |
| March 31, 2026 | 53.90M |
| December 31, 2025 | 63.94M |
| September 30, 2025 | 64.29M |
| June 30, 2025 | 70.01M |
| March 31, 2025 | 77.63M |
| December 31, 2024 | 87.52M |
| September 30, 2024 | 94.96M |
| June 30, 2024 | 101.64M |
| March 31, 2024 | 109.21M |
| December 31, 2023 | 120.22M |
| September 30, 2023 | 127.07M |
| Date | Value |
|---|---|
| June 30, 2023 | 136.13M |
| March 31, 2023 | 146.38M |
| December 31, 2022 | 160.08M |
| September 30, 2022 | 172.94M |
| June 30, 2022 | 191.76M |
| March 31, 2022 | 211.91M |
| December 31, 2021 | 232.11M |
| September 30, 2021 | 245.98M |
| June 30, 2021 | -117.29M |
| March 31, 2021 | -100.80M |
| December 31, 2020 | -88.85M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 1.043B |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 104.87M |
| Total Liabilities (Quarterly) | 51.98M |
| Debt to Equity Ratio | 0.7935 |
| Current Ratio | 4.948 |
| Net Debt Paydown Yield | -0.10% |